• Profile
Close

The efficacy of colloidal oatmeal cream 1% as add-on therapy in the management of chronic irritant hand eczema: A double-blind study

Clinical, Cosmetic and Investigational Dermatology Mar 28, 2020

Sobhan M, et al. - Researchers conducted this double-blind study to assess the clinical advantage of colloidal oatmeal cream in the management of chronic irritant hand eczema (HE). Seventy-nine patients with diagnosis of chronic irritant HE were allocated into either intervention or control groups by block randomization method from October 2018 to November 2019. In addition to 0.025% fluocinolone ointment for the first 2 weeks of treatment period, patients in the intervention and control groups were asked to use 1% colloidal oatmeal cream or base cream as monotherapy for an additional 4 weeks. Fifty individuals (26 in intervention and 24 in control) finished the course of the study. Findings show that in chronic irritant HE patients, colloidal oatmeal, a natural product with proven barrier protection, moisturization, anti-inflammatory, and soothing properties, may have ameliorative effects on eczema severity symptoms.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay